Marie-José Blivet-Van Eggelpoël

Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation

Christèle Desbois‐Mouthon, Axelle Cadoret, Marie-José Blivet-Van Eggelpoël et al. · Oncogene · 2001 · 319 citations

Insulin Signaling, Molecular Physiology, Developmental Biology +12

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells

Marie-José Blivet-Van Eggelpoël, Hamza Chettouh, Lynda Aoudjehane et al. · Journal of Hepatology · 2012 · 174 citations

Hepatocellular Carcinoma, Medicine, Liver Physiology +7

Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma

Christèle Desbois‐Mouthon, Aurore Baron, Marie-José Blivet-Van Eggelpoël et al. · Clinical Cancer Research · 2009 · 153 citations

Insulin-Mediated Cell Proliferation and Survival Involve Inhibition of c-Jun N-terminal Kinases through a Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase Phosphatase-1-Dependent Pathway*

Christèle Desbois‐Mouthon, Axelle Cadoret, Marie-José Blivet-Van Eggelpoël et al. · Endocrinology · 2000 · 45 citations

Jnk Inhibition, Phosphatidylinositol 3-Kinase-, Insulin Signaling +22

Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor

Christèle Desbois‐Mouthon, Claude Danan, Serge Amselem et al. · Metabolism · 1996 · 36 citations

Insulin Resistance, Metabolic Syndrome, Insulin Signaling +15